Suri Venkatachalam is the founder and currently serves as the CEO of Connexios Life Sciences Pvt. Ltd. Connexios a Bangalore based pharmaceutical company that leverages a unique translational network biology approach to discover and develop novel therapeutics for unmet clinical needs in the area of diabetes and diseases of metabolism.He is also a co-founder and chairman of Achira Labs, a Bangalore based start-up developing a diagnostics technology platform based on a unique microfluidics based approach.Before founding Connexios in 2003, Suri was part of the founding team of Metahelix Life Sciences Pvt. Ltd. an Agri-biotech company based in Bangalore. Before, his move to industry, Suri was a Research Associate in Indian Institute of Science, Bangalore; a visiting scientist at the computer science department of Linkoping University, Sweden, an adjunct associate fellow at the National Institute of Advanced Studies, Bangalore and a LJIS Burroughs-Wellcome post doctoral fellow in computational neuroscience at the University of California, San Diego.Suri holds a Bachelors degree in Chemical Engineering and a PhD in condensed matter physics from the Indian Institute of Science.